| 000 | 01582 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515000007.0 | ||
| 264 | 0 | _c20060321 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a1053-8119 | ||
| 024 | 7 |
_a10.1016/j.neuroimage.2005.07.038 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCorripio, Iluminada | |
| 245 | 0 | 0 |
_aStriatal D2 receptor binding as a marker of prognosis and outcome in untreated first-episode psychosis. _h[electronic resource] |
| 260 |
_bNeuroImage _cJan 2006 |
||
| 300 |
_a662-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeostriatum _xdiagnostic imaging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aPsychotic Disorders _xdiagnostic imaging |
| 650 | 0 | 4 | _aPyrrolidines |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xmetabolism |
| 650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPérez, Víctor | |
| 700 | 1 | _aCatafau, Ana M | |
| 700 | 1 | _aMena, Esther | |
| 700 | 1 | _aCarrió, Ignasi | |
| 700 | 1 | _aAlvarez, Enric | |
| 773 | 0 |
_tNeuroImage _gvol. 29 _gno. 2 _gp. 662-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroimage.2005.07.038 _zAvailable from publisher's website |
| 999 |
_c15749622 _d15749622 |
||